T. Rowe Price Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $15M | Sell |
|
|||||
|
2023
Q2 | $34.4M | Sell |
|
|||||
|
2023
Q1 | $52.4M | Sell |
|
|||||
|
2022
Q4 | $72.3M | Sell |
|
|||||
|
2022
Q3 | $48.9M | Sell |
|
|||||
|
2022
Q2 | $63.1M | Sell |
|
|||||
|
2022
Q1 | $85.9M | Sell |
|
|||||
|
2021
Q4 | $91M | Sell |
|
|||||
|
2021
Q3 | $93.6M | Sell |
|
|||||
|
2021
Q2 | $85.2M | Sell |
|
|||||
|
2021
Q1 | $99.1M | Sell |
|
|||||
|
2020
Q4 | $85.3M | Sell |
|
|||||
|
2020
Q3 | $155M | Sell |
|
|||||
|
2020
Q2 | $176M | Buy |
|
|||||
|
2020
Q1 | $56.3M | Buy |
|
|||||
|
2019
Q4 | $66.8M | Buy |
|
|||||
|
2019
Q3 | $44M | Buy |
|
|||||
|
2019
Q2 | $26.5M | Buy |
|
|||||
|
2019
Q1 | $1.55M | Buy |
|
|||||
|
2018
Q4 | $1.13M | Buy |
|
|||||
|
2018
Q3 | $1.13M | Sell |
|
|||||
|
2018
Q2 | $965K | Buy |
|
|||||
|
2018
Q1 | $818K | Buy |
|
|||||
|
2017
Q4 | $834K | Sell |
|
|||||
|
2017
Q3 | $1.02M | Sell |
|
|||||
|
2017
Q2 | $2.42M | Sell |
|
|||||
|
2017
Q1 | $7.94M | Buy |
|
|||||
|
2016
Q4 | $8.45M | Buy |
|
|||||
|
2016
Q3 | $9.23M | Buy |
|
|||||
|
2016
Q2 | $8.11M | Sell |
|
|||||
|
2016
Q1 | $8.34M | Buy |
|
|||||
|
2015
Q4 | $10.7M | Sell |
|
|||||
|
2015
Q3 | $10.3M | Sell |
|
|||||
|
2015
Q2 | $35.3M | Buy |
|
|||||
|
2015
Q1 | $22.4M | Sell |
|
|||||
|
2014
Q4 | $11.2M | Sell |
|
|||||
|
2014
Q3 | $10.9M | Sell |
|
|||||
|
2014
Q2 | $14.1M | Sell |
|
|||||
|
2014
Q1 | $13.6M | Buy |
|
|||||
|
2013
Q4 | $198K | Buy |
|